Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026)
Atea Pharmaceuticals (AVIR) recorded quarterly Tax Provisions of $50000.0 in Q1 2026, up 100.74% quarter-over-quarter from -$6.8 million in Q4 2025, and down 75.37% on a YoY basis from $203000.0 in Q1 2025.
Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 75.37% year-over-year to $50000.0; the TTM figure through Mar 2026 stood at -$6.3 million (down 804.01% YoY), while the FY2025 annual figure was -$6.2 million, down 766.16% from the prior year.
- Tax Provisions was $50000.0 for Q1 2026 at Atea Pharmaceuticals, up from -$6.8 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $349000.0 in Q4 2023 to a low of -$6.8 million in Q4 2025.
- Historically, Tax Provisions has averaged -$484937.5 across 5 years, with a median of $205000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions soared 183.74% in 2023, then sank 3108.0% in 2025.
- A 5-year view of Tax Provisions shows it stood at $123000.0 in 2022, then jumped by 183.74% to $349000.0 in 2023, then tumbled by 35.53% to $225000.0 in 2024, then tumbled by 3108.0% to -$6.8 million in 2025, then surged by 100.74% to $50000.0 in 2026.
- The last three Tax Provisions figures came in at $50000.0 (Q1 2026), -$6.8 million (Q4 2025), and $196000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Atea Pharmaceuticals | 347.28 Mn | 347.28 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | -6.77 Mn |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 243,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | -3.83 Mn |
| Jun 30, 2022 | 120,000.00 |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 6.10 Mn |
| Jun 30, 2021 | 7.20 Mn |